Drugs / AION-301
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT06721143 Comparator | Jan 2025 → Jan 2027 expected | chronic kidney disease | AION Healthspan, Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AION-301 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06721143 ↗ |
| Route | Intravenous | “AION-301 intravenous (IV) infusions” NCT06721143 ↗ |